Head of Integrated Real World Evidence Strategy Department

Pierre Fabre is the 2nd largest dermo-cosmetics laboratory in the world, the 2nd largest private French pharmaceutical group and the market leader in France for products sold over the counter in pharmacies.

Its portfolio includes several medical franchises and international brands including Pierre Fabre Oncologie, Pierre Fabre Dermatologie, Eau Thermale Avène, Klorane, Ducray, René Furterer, A-Derma, Naturactive, Pierre Fabre Oral Care. 

Established in the Occitanie region since its creation, and manufacturing over 95% of its products in France, the Group employs some 10,000 people worldwide. Its products are distributed in about 130 countries. 86% of the Pierre Fabre Group is held by the Pierre Fabre Foundation, a government-recognized public-interest foundation, while a smaller share is owned by its employees via an employee stock ownership plan. 

In 2019, Ecocert Environment assessed the Group's corporate social and environmental responsibility approach in accordance with the ISO 26000 sustainable development standard and awarded it the "Excellence" level.

Pierre Fabre is recognized as one of the "World's Best Employers 2021" by Forbes. Our group is ranked in the Top 3 in the cosmetics industry and in the Top 10 in the pharmaceutical industry worldwide. 

• The Director, Integrated RWE Strategy is accountable for defining and leading the enterprise-level scientific and methodological strategy for real-world evidence generation. The role ensures that RWE is scientifically robust, strategically aligned, and fully integrated within the global evidence ecosystem across R&D, Medical Affairs, Regulatory, HEOR, and Market Access.
• As Head of the Evidence Strategy Leads, the Director provides scientific leadership, governance, and methodological oversight to ensure that real-world data are optimally leveraged to address regulatory, HTA (including EU JCA), payer, and public health decision-making needs across products and programs.

1. RWE Scientific Strategy

• Define and lead the RWE scientific strategy for assigned products, indications, and programs in alignment with medical, regulatory, HTA, and public health priorities.
• Ensure strategic positioning and value of RWE across the product lifecycle.

2. Integrated Evidence Generation

• Lead the RWE contribution to the Integrated Evidence Generation Plan (IEGP).
• Ensure coherence and complementarity of RWE with clinical development, HEOR, Medical Affairs, and Market Access evidence.

3. Regulatory & HTA / JCA Support

• Provide strategic and analytical support for PICO definition within the European Joint Clinical Assessment (JCA) and other HTA processes.
• Identify and leverage RWE opportunities to address comparative effectiveness and evidence gaps.

4. Study Design & Data Sources

• Lead the methodological design of RWE studies, including research questions, study design, and data source selection.
• Assess fitness-for-purpose, quality, and limitations of real-world data sources (claims, EHRs, registries, patient-reported data).

5. Analytics & Statistical Rigor

• Oversee statistical analysis plans in close collaboration with biostatistics.
• Ensure appropriate methods, bias management, confounding adjustment, and robust interpretation of results.

6. Scientific Quality & Deliverables

• Ensure scientific rigor and consistency of RWE deliverables (protocols, reports, abstracts, posters, publications).
• Review and validate RWE studies conducted by affiliates for methodological and strategic alignment.

7. Insights & Stakeholder Communication

• Translate analytical outputs into clear, actionable insights for internal stakeholders (Medical, Regulatory, Market Access).
• Support scientific communication with external stakeholders (HTA bodies, payers, scientific community).

8. Due Diligence & Asset Evaluation

• Contribute to due diligence activities for in-licensing, acquisitions, and pipeline opportunities from an RWE perspective.
• Assess availability, quality, and relevance of real-world data to inform disease understanding, unmet need, comparators, patient pathways, and potential value demonstration.

9. Innovation & Expertise

• Provide subject-matter expertise in observational methods, indirect comparisons, predictive modeling, and longitudinal analyses.
• Maintain continuous scientific and methodological watch in evidence generation and RWE analytics.

10. Capability Building & Leadership

• Contribute to the development of internal RWE capabilities and analytical culture.
• Promote best practices and methodological excellence across global and local teams

We are convinced that diversity is a source of fulfillment, social balance and complementarity for our employees, which is why our offers are open to all, without restriction.